Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE: PRO)

Market Cap	950.00M
Revenue (ttm)	805.52M
Net Income (ttm)	56.90M
Shares Out	1.00M
EPS (ttm)	56.90
PE Ratio	16.70
Forward PE	n/a
Dividend	40.00 (4.21%)
Ex-Dividend Date	n/a

Volume	219
Open	950.00
Previous Close	950.40
Day's Range	950.00 - 950.00
52-Week Range	900.00 - 1,150.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 25, 2025

About PRO

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco. Societe de Promotion Pharmaceutique du Maghreb S.A. operates as a subsidiary of Hikma Pharmaceuticals PLC.

• Industry: Pharmaceutical Preparations
• Founded: 1947
• Employees: 343
• Stock Exchange: Casablanca Stock Exchange
• Ticker Symbol: PRO

Financial Performance

In 2023, PRO's revenue was 805.52 million, an increase of 14.32% compared to the previous year's 704.64 million. Earnings were 56.90 million, a decrease of -24.42%.